Alfred D Kinana1, Attilio V Vargiu2, Hiroshi Nikaido3. 1. Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3202, USA. 2. Department of Physics, University of Cagliari, 09042, Monserrato, Italy. 3. Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720-3202, USA. Electronic address: nhiroshi@berkeley.edu.
Abstract
BACKGROUND: The Resistance-Nodulation-Division (RND) family transporter AcrB plays a major role in the intrinsic and increased resistance of Escherichia coli to a large number of antibiotics. The distal binding pocket within this multidrug efflux transporter is very large, but the effort to define the roles of various residues facing this pocket through site-directed mutagenesis so far involved only the determination of minimal inhibitory concentrations of drugs in mutants. METHODS: We measured in intact E. coli cells the kinetics of efflux of two substrates, nitrocefin (a cephalosporin) that is predicted mainly to bind to the upper, "groove" domain of the pocket, and L-alanyl-β-naphthylamide (Ala-Naph) that is likely to bind to the lower, "cave" domain, in a number of site-directed mutants of AcrB, where a hydrophobic or aromatic residue was changed into alanine. RESULTS: The efflux of nitrocefin became attenuated by some mutations in the groove domain, such as I278A and F178A, but in some experiments a mutation in the cave domain, F628A produced a similar result. In some cases an increased value of KM was detected. The efflux of Ala-Naph was increased by mutations in the cave domain, such as F136A and I626A, but also by those in the groove domain (I277A, I278A, F178A). In most cases the increased Vmax values appeared to be responsible. F610A mutation had a profound effect on the efflux of both substrates, as reported earlier. CONCLUSIONS: Our data show for the first time effects of various substrate-binding pocket mutations on the kinetics of efflux of two substrates by the AcrB pump. They also confirm interactions between substrates and drugs predicted by MD simulation studies, and also reveal areas that need future research.
BACKGROUND: The Resistance-Nodulation-Division (RND) family transporter AcrB plays a major role in the intrinsic and increased resistance of Escherichia coli to a large number of antibiotics. The distal binding pocket within this multidrug efflux transporter is very large, but the effort to define the roles of various residues facing this pocket through site-directed mutagenesis so far involved only the determination of minimal inhibitory concentrations of drugs in mutants. METHODS: We measured in intact E. coli cells the kinetics of efflux of two substrates, nitrocefin (a cephalosporin) that is predicted mainly to bind to the upper, "groove" domain of the pocket, and L-alanyl-β-naphthylamide (Ala-Naph) that is likely to bind to the lower, "cave" domain, in a number of site-directed mutants of AcrB, where a hydrophobic or aromatic residue was changed into alanine. RESULTS: The efflux of nitrocefin became attenuated by some mutations in the groove domain, such as I278A and F178A, but in some experiments a mutation in the cave domain, F628A produced a similar result. In some cases an increased value of KM was detected. The efflux of Ala-Naph was increased by mutations in the cave domain, such as F136A and I626A, but also by those in the groove domain (I277A, I278A, F178A). In most cases the increased Vmax values appeared to be responsible. F610A mutation had a profound effect on the efflux of both substrates, as reported earlier. CONCLUSIONS: Our data show for the first time effects of various substrate-binding pocket mutations on the kinetics of efflux of two substrates by the AcrB pump. They also confirm interactions between substrates and drugs predicted by MD simulation studies, and also reveal areas that need future research.
Authors: Thomas Eicher; Hi-jea Cha; Markus A Seeger; Lorenz Brandstätter; Jasmin El-Delik; Jürgen A Bohnert; Winfried V Kern; François Verrey; Markus G Grütter; Kay Diederichs; Klaas M Pos Journal: Proc Natl Acad Sci U S A Date: 2012-03-26 Impact factor: 11.205
Authors: Attilio V Vargiu; Francesca Collu; Robert Schulz; Klaas M Pos; Martin Zacharias; Ulrich Kleinekathöfer; Paolo Ruggerone Journal: J Am Chem Soc Date: 2011-06-27 Impact factor: 15.419
Authors: Jessica M A Blair; Vassiliy N Bavro; Vito Ricci; Niraj Modi; Pierpaolo Cacciotto; Ulrich Kleinekathӧfer; Paolo Ruggerone; Attilio V Vargiu; Alison J Baylay; Helen E Smith; Yvonne Brandon; David Galloway; Laura J V Piddock Journal: Proc Natl Acad Sci U S A Date: 2015-03-03 Impact factor: 11.205
Authors: Hanno Sjuts; Attilio V Vargiu; Steven M Kwasny; Son T Nguyen; Hong-Suk Kim; Xiaoyuan Ding; Alina R Ornik; Paolo Ruggerone; Terry L Bowlin; Hiroshi Nikaido; Klaas M Pos; Timothy J Opperman Journal: Proc Natl Acad Sci U S A Date: 2016-03-14 Impact factor: 11.205
Authors: Jürgen A Bohnert; Sabine Schuster; Markus A Seeger; Eva Fähnrich; Klaas M Pos; Winfried V Kern Journal: J Bacteriol Date: 2008-10-10 Impact factor: 3.490
Authors: Tamar Schlick; Stephanie Portillo-Ledesma; Christopher G Myers; Lauren Beljak; Justin Chen; Sami Dakhel; Daniel Darling; Sayak Ghosh; Joseph Hall; Mikaeel Jan; Emily Liang; Sera Saju; Mackenzie Vohr; Chris Wu; Yifan Xu; Eva Xue Journal: Annu Rev Biophys Date: 2021-02-19 Impact factor: 12.981
Authors: Xuan Wang-Kan; Jessica M A Blair; Barbara Chirullo; Jonathan Betts; Roberto M La Ragione; Alasdair Ivens; Vito Ricci; Timothy J Opperman; Laura J V Piddock Journal: MBio Date: 2017-07-18 Impact factor: 7.867
Authors: Elizabeth M Grimsey; Chiara Fais; Robert L Marshall; Vito Ricci; Maria Laura Ciusa; Jack W Stone; Alasdair Ivens; Giuliano Malloci; Paolo Ruggerone; Attilio V Vargiu; Laura J V Piddock Journal: mBio Date: 2020-06-02 Impact factor: 7.867